James W. McCollum, Director at LENZ Therapeutics, Inc. (LENZ), bought 62,664 shares at $15.99 ($1.0M) on 2024-05-13, disclosed to the SEC on 2024-05-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.99 | 31,332 | $501K | 50.0% |
| 2 | $15.99 | 31,332 | $501K | 50.0% |
| Total | $15.99 avg | 62,664 | $1.0M | 100% |